The more controversial of two papers describing how the lethal H5N1 bird flu could be made easier to spread was published Thursday, six months after a scientific advisory board suggested that the papers’ most potentially dangerous data be censored.The paper, by scientists at Erasmus Medical Center i

The study suggests that the price of patented medicine in Thailand should be controlled based on equity pricing and outcome pricing. Equity pricing can be estimated from the international reference price and outcome pricing can be evaluated from therapeutic referencing or the pharmacoeconomic price. Moreover, in a case study of 7 medicines granted

The objective of this study is to estimate the cost-utility analysis of the cholinesterase inhibitors (i.e., donepezil, galantamine and rivastigmine) compared with no drug treatment in patients with mild to moderate alzheimer’s disease (AD) in Thailand based on the societal and governmental perspectives and to estimate the budget impact of the ch

The settlement is part of a broad crackdown on bribery by multinational companies in foreign countries that has hit several of the world’s biggest pharmaceutical companies.Pfizer in 2004 became the first pharmaceutical company to volunteer information about past wrongdoing to the Justice Department,

Patients with Down’s syndrome have developmental delay and abnormalities in their biological system. Most of the patients cannot take care of themselves. They must have long term treatment which is quite expensive. Currently there is no curative therapy for Down’s syndrome. Screening and prenatal diagnosis to detect abnormalities of Down’s sy

The debate over the price of the vaccine against HPV has become intenseWhen it comes to making the shot against cervical cancer the national vaccine programme, which means girls between the ages of 12-18 will receive it free, price is the matter.The debate over the price of the vaccine against Human

At the 67th World Health Assembly in Geneva in May 2014, a resolution was adopted on Health intervention and technology assessment in support of universal health coverage. Prof David Haslam, Chair of NICE, representing the UK Mission Geneva, addressed the Assembly during a panel session on the role

In 2007, there were an estimated 58 million deaths worldwide and, according to the WHO, more than half of these deaths (35 million) were caused by chronic diseases.  Another study estimates that the number of deaths caused by chronic diseases will rise to 50 million in 2020.  The economic burden of

On April 7-10, 2015, a HITAP team visited Dar es Salaam, Tanzania, for a country scoping visit to explore the potential areas for introducing health technology assessment (HTA) to support health resource allocation, focusing on the investment or disinvestment of health technologies. This visit was c

Quality and Outcomes Framework Steering Meeting 15 March 2016 Thailand adopted in 2013 the Quality and Outcomes Framework, also known as the QOF. This program was initiated by the National Health Security Office (NHSO) in Thailand that is responsi